Viitanen J, Malminiemi K, Kallio J, Puolakka V M, Rajala P, Tammela T L
North Karelian Central Hospital, Joensuu, Finland.
Chemotherapy. 1998 Jan-Feb;44(1):69-75. doi: 10.1159/000007093.
We compared oral fleroxacin and cefalexin in the prevention of postoperative infectious complications after transurethral prostatectomy (TURP) in patients with preoperative bacteriuria. 95 patients underwent TURP due to benign prostatic hyperplasia with preoperative bacteriuria. The therapy consisted of 7 days of oral fleroxacin 400 mg once a day or cefalexin 500 mg three times daily. After 2 weeks, 62% of the urine samples were sterile in the fleroxacin groups but only 37% in the cefalexin group (p = 0.047). Patients in the cefalexin group had also statistically significantly more symptoms of urinary tract infections. After 6 weeks, the bacterial eradication rate was 53% in the fleroxacin group and 37% in the cefalexin group. There were no septicemias. TURP can be performed with reasonable safety with this oral antibiotic therapy.
我们比较了口服氟罗沙星和头孢氨苄对术前有菌尿的经尿道前列腺切除术(TURP)患者术后感染并发症的预防作用。95例因良性前列腺增生伴术前菌尿而接受TURP的患者。治疗方案为口服氟罗沙星400mg,每日1次,共7天,或头孢氨苄500mg,每日3次。2周后,氟罗沙星组62%的尿样无菌,而头孢氨苄组仅为37%(p = 0.047)。头孢氨苄组患者的尿路感染症状在统计学上也显著更多。6周后,氟罗沙星组的细菌清除率为53%,头孢氨苄组为37%。未发生败血症。采用这种口服抗生素治疗,TURP可以在合理的安全性下进行。